Production of cysteinyl-dopamine during intravenous dopamine therapy-Reference-Cited by-同舟云学术

Production of cysteinyl-dopamine during intravenous dopamine therapy

Published:2001-05 Issue:5 Volume:59 Page:1891-1898
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Magnay Julia L.,Tong Jeff,Drangova Rosa,Baines Andrew D.

Publisher

Elsevier BV

Subject

Nephrology

Reference25 articles.

1. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydoxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro;Graham;Mol Pharmacol,1978

2. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture;Michel;J Neurosci Res,1990

3. An in vitro bacterial model of cytotoxicity to living cells caused by dopamine and 6-hydroxydopamine oxidation at physiological pH;Giunta;Free Radic Biol Med,1991

4. Detection of 5-S-cysteinyldopamine in human brain;Rosengren;J Neural Trans,1985

5. Inhibition of human glutathione S-transferase by dopamine, alpha-methyldopa and their 5-S-glutathionyl conjugates;Ploemen;Chem Biol Interact,1994

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebrospinal fluid concentration gradients of catechols in synucleinopathies;Journal of Neurochemistry;2024-06-28

2. The mercapturomic profile of health and non-communicable diseases;High-Throughput;2019-04-23

3. Mercapturate Pathway in the Tubulocentric Perspective of Diabetic Kidney Disease;Nephron;2019

4. Targeting redox regulation to treat substance use disorder using N‐acetylcysteine;European Journal of Neuroscience;2018-09-24

5. Roles of catechol neurochemistry in autonomic function testing;Clinical Autonomic Research;2018-04-28